DalsnaFinance › IPOs › Amylyx Pharmaceuticals Inc › IPO
Amylyx Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on January 7, 2022, pricing at $19.00 a share.
| Ticker | AMLX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 7, 2022 |
| Offering price | $19.00 |
| Shares offered | 10,000,000 |
| Total raised | $190M |
Amylyx Pharmaceuticals, Inc. sold 10,000,000 shares at $19.00 each on NASDAQ. Multiplied out, that is $190 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $190 million total recorded for the deal.
Amylyx Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Amylyx Pharmaceuticals, Inc.. This page is general information, not investment advice.